2020
PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders
Jamwal S, Blackburn J, Elsworth JD. PPARγ/PGC1α signaling as a potential therapeutic target for mitochondrial biogenesis in neurodegenerative disorders. Pharmacology & Therapeutics 2020, 219: 107705. PMID: 33039420, PMCID: PMC7887032, DOI: 10.1016/j.pharmthera.2020.107705.Peer-Reviewed Original ResearchConceptsNeurodegenerative disordersParkinson's diseaseAlzheimer's diseaseParaoxonase 2Mitochondrial biogenesisNeurodegenerative diseasesHuntington's diseasePeroxisome proliferator-activated receptorProliferator-activated receptorPotential therapeutic targetDevastating neurological disorderFunction of neuronsPeroxisome proliferator-activated receptor gamma co-activator-1 alphaPharmacological-based therapiesSymptomatic treatmentCurrent therapiesClinical trialsLigand-inducible transcription factorsTherapeutic targetNeurological disordersDiseasePPARγ modulatorsProgressive lossMitochondrial dysfunctionPromising target
2019
C‐terminal phosphorylation of latrophilin‐1/ADGRL1 affects the interaction between its fragments
Rahman M, Manser C, Benlaouer O, Suckling J, Blackburn J, Silva J, Ushkaryov Y. C‐terminal phosphorylation of latrophilin‐1/ADGRL1 affects the interaction between its fragments. Annals Of The New York Academy Of Sciences 2019, 1456: 122-143. PMID: 31553068, DOI: 10.1111/nyas.14242.Peer-Reviewed Original ResearchConceptsN-terminal fragmentG protein-coupled receptorsC-terminal fragmentLatrophilin-1Protein-coupled receptorsAdhesion G protein-coupled receptorsProtein tyrosine phosphatase σG protein-mediated signalingProtein-mediated signalingPhosphorylated C-terminal fragmentsTerminal phosphorylationIndependent proteinsPlasma membraneSeparate proteinsΑ-latrotoxinAffinity columnProteinEndocrine cellsFragmentsHigh affinityLow affinityMultiple sitesCopurifiesDephosphorylationComplexes
2018
Proteolytically released Lasso/teneurin-2 induces axonal attraction by interacting with latrophilin-1 on axonal growth cones
Vysokov NV, Silva JP, Lelianova VG, Suckling J, Cassidy J, Blackburn JK, Yankova N, Djamgoz MB, Kozlov SV, Tonevitsky AG, Ushkaryov YA. Proteolytically released Lasso/teneurin-2 induces axonal attraction by interacting with latrophilin-1 on axonal growth cones. ELife 2018, 7: e37935. PMID: 30457553, PMCID: PMC6245728, DOI: 10.7554/elife.37935.Peer-Reviewed Original ResearchConceptsLatrophilin-1Axonal growth conesAxonal attractionAdhesion G protein-coupled receptorsPostsynaptic transmembrane proteinsG protein-coupled receptorsGrowth conesTrans-synaptic interactionsGrowth cone steeringRegulated proteolysisTransmembrane proteinDownstream signalingAxonal pathfindingNeuronal developmentEnhanced exocytosisNovel mechanismSynapse formationNeurite outgrowthTeneurinsIntercellular spacesCytosolic calciumStable gradientSynaptogenesisExocytosisSignaling
2016
Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells
Sumbayev V, Silva I, Blackburn J, Gibbs B, Yasinska I, Garrett M, Tonevitsky A, Ushkaryov Y. Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells. Oncotarget 2016, 7: 45575-45583. PMID: 27322212, PMCID: PMC5216743, DOI: 10.18632/oncotarget.10039.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaTreatment of AMLPrimary human AML cellsHuman acute myeloid leukemia cellsAcute myeloid leukemia cellsLeukemia cellsHuman acute myeloid leukemiaHealthy leukocytesHuman AML cellsLatrophilin-1Myeloid leukemia cellsSerious medical burdenHuman monocytic leukemia cell lineMonocytic leukemia cell lineAML diagnosisSystemic diseaseMedical burdenMyeloid leukemiaAML cellsNovel biomarkersPotential new avenuesBone marrowLeukemia cell linesMalignant cellsBlood cancers